Literature DB >> 24515454

The odyssey of a young gene: structure-function studies in human glutamate dehydrogenases reveal evolutionary-acquired complex allosteric regulation mechanisms.

Ioannis V Zaganas1, Konstantinos Kanavouras, Nikolas Borompokas, Giovanna Arianoglou, Christina Dimovasili, Helen Latsoudis, Metaxia Vlassi, Vasileios Mastorodemos.   

Abstract

Mammalian glutamate dehydrogenase (GDH) catalyzes the reversible inter-conversion of glutamate to α-ketoglutarate and ammonia, interconnecting carbon skeleton and nitrogen metabolism. In addition, it functions as an energy switch by its ability to fuel the Krebs cycle depending on the energy status of the cell. As GDH lies at the intersection of several metabolic pathways, its activity is tightly regulated by several allosteric compounds that are metabolic intermediates. In contrast to other mammals that have a single GDH-encoding gene, humans and great apes possess two isoforms of GDH (hGDH1 and hGDH2, encoded by the GLUD1 and GLUD2 genes, respectively) with distinct regulation pattern, but remarkable sequence similarity (they differ, in their mature form, in only 15 of their 505 amino-acids). The GLUD2 gene is considered a very young gene, emerging from the GLUD1 gene through retro-position only recently (<23 million years ago). The new hGDH2 iso-enzyme, through random mutations and natural selection, is thought to have conferred an evolutionary advantage that helped its persistence through primate evolution. The properties of the two highly homologous human GDHs have been studied using purified recombinant hGDH1 and hGDH2 proteins obtained by expression of the corresponding cDNAs in Sf21 cells. According to these studies, in contrast to hGDH1 that maintains basal activity at 35-40 % of its maximal, hGDH2 displays low basal activity that is highly responsive to activation by rising levels of ADP and/or L-leucine which can also act synergistically. While hGDH1 is inhibited potently by GTP, hGDH2 shows remarkable GTP resistance. Furthermore, the two iso-enzymes are differentially inhibited by estrogens, polyamines and neuroleptics, and also differ in heat-lability. To elucidate the molecular mechanisms that underlie these different regulation patterns of the two iso-enzymes (and consequently the evolutionary adaptation of hGDH2 to a new functional role), we have performed mutagenesis at sites of difference in their amino acid sequence. Results showed that the low basal activity, heat-lability and estrogen sensitivity of hGDH2 could be, at least partially, ascribed to the Arg443Ser evolutionary change, whereas resistance to GTP inhibition has been attributed to the Gly456Ala change. Other amino acid substitutions studied thus far cannot explain all the remaining functional differences between the two iso-enzymes. Also, the Arg443Ser/Gly456Ala double mutation in hGDH1 approached the properties of wild-type hGDH2, without being identical to it. The insights into the structural mechanism of enzymatic regulation and the implications in cell biology provided by these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24515454     DOI: 10.1007/s11064-014-1251-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  77 in total

1.  Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene.

Authors:  C A Stanley; Y K Lieu; B Y Hsu; A B Burlina; C R Greenberg; N J Hopwood; K Perlman; B H Rich; E Zammarchi; M Poncz
Journal:  N Engl J Med       Date:  1998-05-07       Impact factor: 91.245

Review 2.  Regulation of human glutamate dehydrogenases: implications for glutamate, ammonia and energy metabolism in brain.

Authors:  A Plaitakis; I Zaganas
Journal:  J Neurosci Res       Date:  2001-12-01       Impact factor: 4.164

Review 3.  Revisiting the TCA cycle: signaling to tumor formation.

Authors:  Nuno Raimundo; Bora E Baysal; Gerald S Shadel
Journal:  Trends Mol Med       Date:  2011-07-20       Impact factor: 11.951

4.  Glutamate dehydrogenase activation and ammonia formation by rat kidney mitochondria.

Authors:  A C Schoolwerth; B L Nazar; K F LaNoue
Journal:  J Biol Chem       Date:  1978-09-10       Impact factor: 5.157

5.  Structural basis for leucine-induced allosteric activation of glutamate dehydrogenase.

Authors:  Takeo Tomita; Tomohisa Kuzuyama; Makoto Nishiyama
Journal:  J Biol Chem       Date:  2011-09-06       Impact factor: 5.157

6.  The complex regulation of human glud1 and glud2 glutamate dehydrogenases and its implications in nerve tissue biology.

Authors:  Cleanthe Spanaki; Ioannis Zaganas; Zuzana Kounoupa; Andreas Plaitakis
Journal:  Neurochem Int       Date:  2012-05-30       Impact factor: 3.921

7.  Stimulation of pancreatic islet metabolism and insulin release by a nonmetabolizable amino acid.

Authors:  A Sener; F Malaisse-Lagae; W J Malaisse
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

8.  Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset.

Authors:  Andreas Plaitakis; Helen Latsoudis; Konstantinos Kanavouras; Beate Ritz; Jeff M Bronstein; Irene Skoula; Vasileios Mastorodemos; Spyridon Papapetropoulos; Nikolas Borompokas; Ioannis Zaganas; Georgia Xiromerisiou; George M Hadjigeorgiou; Cleanthe Spanaki
Journal:  Eur J Hum Genet       Date:  2009-10-14       Impact factor: 4.246

9.  The pathway of glutamate metabolism in rat brain mitochondria.

Authors:  S C Dennis; J B Clark
Journal:  Biochem J       Date:  1977-12-15       Impact factor: 3.857

10.  Identification of amino acid residues responsible for different GTP preferences of human glutamate dehydrogenase isozymes.

Authors:  Myung-Min Choi; Eun Young Hwang; Eun-A Kim; Jae-Wan Huh; Sung-Woo Cho
Journal:  Biochem Biophys Res Commun       Date:  2008-02-07       Impact factor: 3.575

View more
  5 in total

1.  Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1R132H-Induced Metabolic Liabilities.

Authors:  Matthew S Waitkus; Christopher J Pirozzi; Casey J Moure; Bill H Diplas; Landon J Hansen; Austin B Carpenter; Rui Yang; Zhaohui Wang; Brian O Ingram; Edward D Karoly; Robert P Mohney; Ivan Spasojevic; Roger E McLendon; Henry S Friedman; Yiping He; Darell D Bigner; Hai Yan
Journal:  Cancer Res       Date:  2017-11-02       Impact factor: 12.701

Review 2.  Multiple Forms of Glutamate Dehydrogenase in Animals: Structural Determinants and Physiological Implications.

Authors:  Victoria Bunik; Artem Artiukhov; Vasily Aleshin; Garik Mkrtchyan
Journal:  Biology (Basel)       Date:  2016-12-14

Review 3.  Amino Acid Catabolism in Alzheimer's Disease Brain: Friend or Foe?

Authors:  Jeddidiah W D Griffin; Patrick C Bradshaw
Journal:  Oxid Med Cell Longev       Date:  2017-02-05       Impact factor: 6.543

4.  Sirtuin 4 Inhibits Prostate Cancer Progression and Metastasis by Modulating p21 Nuclear Translocation and Glutamate Dehydrogenase 1 ADP-Ribosylation.

Authors:  Liang Mao; Xi Hong; Luwei Xu; Xinning Wang; Jingyu Liu; Hao Wang; Yiguan Qian; Jun Zhao; Ruipeng Jia
Journal:  J Oncol       Date:  2022-07-07       Impact factor: 4.501

5.  Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism.

Authors:  Andrea Cacace; Martina Sboarina; Thibaut Vazeille; Pierre Sonveaux
Journal:  Oncogene       Date:  2016-10-17       Impact factor: 9.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.